Amanta Healthcare Ltd.

133.49

1.2 (0.9%)growUp

As on June 5, 2026
SectorNA
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap524 Cr
P/E Ratio36.65
Dividend YieldN/A
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open132.92
High136.81
NSE SymbolAMANTA
Close133.49
Low129.03
BSE Symbol544502
Previous Years High/Low
1 Year High154.4
3 Year High154.4
5 Year High154.4
1 Year Low92
3 Year Low92
5 Year Low92

Technicals


IndicatorsValueSignal
5-DMA124.92Bullish
10-DMA127.75Bullish
20-DMA129.61Bullish
50-DMA123.65Bullish
100-DMA113.44Bullish
200-DMA---

Historical Performance


1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 36.65, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered price CAGR data is unavailable.
  • The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹611 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹2747 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 941728.4
No. of Shares: 7055 (Approx)
Performance:-5.8%
P/L: ₹-58271.6
NIFTY Performance: -6.5%
1 day Top Gainers
SymbolChange%
ZEEL112.27(8%)
ADANIGREEN1525.7(7%)
HSCL685.05(7%)
JYOTICNC634.3(6%)
SCHNEIDER1172.2(6%)
1 Day Top Losers
SymbolChange%
WOCKPHARMA1920.9(-7%)
HINDZINC566.8(-6%)
NETWEB4666(-5%)
HFCL187.23(-5%)
NATIONALUM395.7(-4%)
TEJASNET576.2(-4%)
BSE3880(-4%)
VEDL315.6(-4%)

Top Performing Stocks from the same sector


Venus Remedies Ltd.

72%

1633.5

1 Month Performance

Bliss GVS Pharma Ltd.

62.5%

438.35

1 Month Performance

Sun Pharma Advanced Research Company Ltd.

52%

212.82

1 Month Performance

Panacea Biotec Ltd.

45.7%

540.2

1 Month Performance

IOL Chemicals And Pharmaceuticals Ltd.

39.2%

131.68

1 Month Performance

Supriya Lifescience Ltd.

37.2%

947.95

1 Month Performance

Orchid Pharma Ltd.

34.6%

844.25

1 Month Performance

Novartis India Ltd.

34.2%

1391.1

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month